Are you an early-stage investor?
Do you have a company and want to take it public?
Join us for casual conversation, drinks and appetizers on Wednesday, January 30th from 4-7PM
InSitu Biologics & Manhattan Street Capital brings you expert insight on raising capital in Biotech and Life Sciences. Plus, network with other local companies & investors.
4:00PM – 4:30PM Networking
4:30PM – 4:45PM Welcome / Introduction
4:45PM – 5:05PM Breakaway Session #1
5:15PM – 5:35PM Breakaway Session #2
5:45PM – 7:00PM Networking
Session #1 – Regulation A+ public offering
Rod Turner, CEO Manhattan Street Capital
San Diego-based Manhattan Street Capital
Session #2 – InSitu Biologics – Matrix BioHydrogel™ & AnestaGel™
Jim Segermark, CEO InSitu Biologics
Non-Opiate Painkiller, over 22+ Patents Issued, Market Cap of Only $77 million
About InSitu Biologics
InSitu Biologics is an emerging biotech company, with a highly developed non-opiate painkiller that is expected to be studied in people this year. Nearly $3m raised with Manhattan Street Capital using Regulation A+. www.insitubiologics.com
About Manhattan Street Capital
Manhattan Street Capital is the premier online fundraising platform for Regulation A+ and Private Offerings. www.manhattanstreetcapital.com
For more information contact
Jim Segermark, CEO of InSitu Biologics
1-651-338-4801 | Jim@insitubiologics.com
From Jan 30, 2019 04:00PM to Jan 30, 2019 07:00PM at Prado, 1549 El Prado, San Diego, CA 92101, USA (Garden Terrace)